Health-related quality of life from the MM-003 trial of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed and/or refractory multiple myeloma

Standard

Health-related quality of life from the MM-003 trial of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed and/or refractory multiple myeloma. / Song, Kevin W; Dimopoulos, Meletios A; Weisel, Katja C; Moreau, Philippe; Palumbo, Antonio; Belch, Andrew; Schey, Stephen; Sonneveld, Pieter; Sternas, Lars; Yu, Xin; Amatya, Ramesh; Monzini, Mara S; Zaki, Mohamed; Jacques, Christian; San Miguel, Jesus.

in: HAEMATOLOGICA, Jahrgang 100, Nr. 2, 02.2015, S. e63-7.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Song, KW, Dimopoulos, MA, Weisel, KC, Moreau, P, Palumbo, A, Belch, A, Schey, S, Sonneveld, P, Sternas, L, Yu, X, Amatya, R, Monzini, MS, Zaki, M, Jacques, C & San Miguel, J 2015, 'Health-related quality of life from the MM-003 trial of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed and/or refractory multiple myeloma', HAEMATOLOGICA, Jg. 100, Nr. 2, S. e63-7. https://doi.org/10.3324/haematol.2014.112557

APA

Song, K. W., Dimopoulos, M. A., Weisel, K. C., Moreau, P., Palumbo, A., Belch, A., Schey, S., Sonneveld, P., Sternas, L., Yu, X., Amatya, R., Monzini, M. S., Zaki, M., Jacques, C., & San Miguel, J. (2015). Health-related quality of life from the MM-003 trial of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed and/or refractory multiple myeloma. HAEMATOLOGICA, 100(2), e63-7. https://doi.org/10.3324/haematol.2014.112557

Vancouver

Bibtex

@article{30f2c1552eda45a3b20cdca9e7bf7670,
title = "Health-related quality of life from the MM-003 trial of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed and/or refractory multiple myeloma",
keywords = "Antineoplastic Combined Chemotherapy Protocols, Cross-Sectional Studies, Dexamethasone, Dose-Response Relationship, Drug, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Multiple Myeloma, Neoplasm Recurrence, Local, Neoplasm Staging, Prognosis, Quality of Life, Thalidomide, Comparative Study, Letter, Randomized Controlled Trial, Research Support, Non-U.S. Gov't",
author = "Song, {Kevin W} and Dimopoulos, {Meletios A} and Weisel, {Katja C} and Philippe Moreau and Antonio Palumbo and Andrew Belch and Stephen Schey and Pieter Sonneveld and Lars Sternas and Xin Yu and Ramesh Amatya and Monzini, {Mara S} and Mohamed Zaki and Christian Jacques and {San Miguel}, Jesus",
year = "2015",
month = feb,
doi = "10.3324/haematol.2014.112557",
language = "English",
volume = "100",
pages = "e63--7",
journal = "HAEMATOLOGICA",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "2",

}

RIS

TY - JOUR

T1 - Health-related quality of life from the MM-003 trial of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed and/or refractory multiple myeloma

AU - Song, Kevin W

AU - Dimopoulos, Meletios A

AU - Weisel, Katja C

AU - Moreau, Philippe

AU - Palumbo, Antonio

AU - Belch, Andrew

AU - Schey, Stephen

AU - Sonneveld, Pieter

AU - Sternas, Lars

AU - Yu, Xin

AU - Amatya, Ramesh

AU - Monzini, Mara S

AU - Zaki, Mohamed

AU - Jacques, Christian

AU - San Miguel, Jesus

PY - 2015/2

Y1 - 2015/2

KW - Antineoplastic Combined Chemotherapy Protocols

KW - Cross-Sectional Studies

KW - Dexamethasone

KW - Dose-Response Relationship, Drug

KW - Female

KW - Follow-Up Studies

KW - Humans

KW - Longitudinal Studies

KW - Male

KW - Middle Aged

KW - Multiple Myeloma

KW - Neoplasm Recurrence, Local

KW - Neoplasm Staging

KW - Prognosis

KW - Quality of Life

KW - Thalidomide

KW - Comparative Study

KW - Letter

KW - Randomized Controlled Trial

KW - Research Support, Non-U.S. Gov't

U2 - 10.3324/haematol.2014.112557

DO - 10.3324/haematol.2014.112557

M3 - SCORING: Journal article

C2 - 25425684

VL - 100

SP - e63-7

JO - HAEMATOLOGICA

JF - HAEMATOLOGICA

SN - 0390-6078

IS - 2

ER -